KURAKura Oncology, Inc.
What is the market doing?
Rangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Choppy, but holding above its 200-day average. Oversold (RSI 22). Price is +7% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How KURA is trading
Kura Oncology, Inc. is +11% over the past year while the S&P 500 is +18%: 6.8 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +7.1%
vs 200-day average · close to trend
- RSI (14)
- 22
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 23%
Below its 52-week high
Details›
- Last close2026-10-08
- $10.51
- 1 monthS&P 500 +1.6%
- −13%
- 1 yearS&P 500 +18%
- +11%
- 5 yearsS&P 500 +86%
- −44%
- vs 50-day average$11.24
- −6.5%
- 52-week high
- $13.59
- 52-week low
- $7.40
- Annualised volatility
- 63%
| Year | Return |
|---|---|
| 2026 (year to date) | +1.2% |
| 2025 | +19% |
| 2024 | −39% |
| 2023 | +16% |
| 2022 | −11% |
| 2021 | −57% |
| 2020 | +138% |
| 2019 | −2.1% |
| 2018 | −8.2% |
| 2017 | +159% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +4.5% |
| Feb | 10 | 6 of 10 | +5.0% |
| Mar | 10 | 6 of 10 | −3.6% |
| Apr | 10 | 3 of 10 | −0.45% |
| May | 10 | 6 of 10 | +4.1% |
| Jun | 10 | 6 of 10 | +5.4% |
| Jul | 11 | 5 of 11 | +1.8% |
| Aug | 11 | 6 of 11 | +9.7% |
| Sep | 11 | 5 of 11 | +9.6% |
| Oct | 11 | 3 of 11 | −7.2% |
| Nov | 10 | 8 of 10 | +5.2% |
| Dec | 10 | 4 of 10 | −0.41% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.